These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21437989)

  • 1. Neurocognitive effects of kava (Piper methysticum): a systematic review.
    LaPorte E; Sarris J; Stough C; Scholey A
    Hum Psychopharmacol; 2011 Mar; 26(2):102-11. PubMed ID: 21437989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced cognitive performance and cheerful mood by standardized extracts of Piper methysticum (Kava-kava).
    Thompson R; Ruch W; Hasenöhrl RU
    Hum Psychopharmacol; 2004 Jun; 19(4):243-50. PubMed ID: 15181652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kava extract for treating anxiety.
    Pittler MH; Edzard E
    Cochrane Database Syst Rev; 2001; (4):CD003383. PubMed ID: 11687196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health policy versus kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop.
    Thomsen M; Schmidt M
    J Ethnopharmacol; 2021 Mar; 268():113582. PubMed ID: 33189846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kava extract for treating anxiety.
    Pittler MH; Ernst E
    Cochrane Database Syst Rev; 2002; (2):CD003383. PubMed ID: 12076477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of kava in the treatment of anxiety disorders.
    Singh YN; Singh NN
    CNS Drugs; 2002; 16(11):731-43. PubMed ID: 12383029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.
    Sarris J; Kavanagh DJ
    J Altern Complement Med; 2009 Aug; 15(8):827-36. PubMed ID: 19614563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis.
    Pittler MH; Ernst E
    J Clin Psychopharmacol; 2000 Feb; 20(1):84-9. PubMed ID: 10653213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kava: a comprehensive review of efficacy, safety, and psychopharmacology.
    Sarris J; LaPorte E; Schweitzer I
    Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study.
    Sarris J; Scholey A; Schweitzer I; Bousman C; Laporte E; Ng C; Murray G; Stough C
    Hum Psychopharmacol; 2012 May; 27(3):262-9. PubMed ID: 22311378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effects of Kava (Piper Methysticum) constituents in cancers: A systematic review.
    Celentano A; Tran A; Testa C; Thayanantha K; Tan-Orders W; Tan S; Syamal M; McCullough MJ; Yap T
    J Oral Pathol Med; 2019 Aug; 48(7):510-529. PubMed ID: 31172600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of the safety of kava extract in the treatment of anxiety.
    Stevinson C; Huntley A; Ernst E
    Drug Saf; 2002; 25(4):251-61. PubMed ID: 11994028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurobehavioural effects of kava.
    Cairney S; Maruff P; Clough AR
    Aust N Z J Psychiatry; 2002 Oct; 36(5):657-62. PubMed ID: 12225450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saccade and cognitive impairment associated with kava intoxication.
    Cairney S; Maruff P; Clough AR; Collie A; Currie J; Currie BJ
    Hum Psychopharmacol; 2003 Oct; 18(7):525-33. PubMed ID: 14533134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, in vitro, reactivity, and identification of 6-phenyl-3-hexen-2-one in human urine after kava-kava (Piper methysticum) ingestion.
    Zou L; Harkey MR; Henderson GL
    Planta Med; 2005 Feb; 71(2):142-6. PubMed ID: 15729622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional preparations of kava (Piper methysticum) inhibit the growth of human colon cancer cells in vitro.
    Einbond LS; Negrin A; Kulakowski DM; Wu HA; Antonetti V; Jalees F; Law W; Roller M; Redenti S; Kennelly EJ; Balick MJ
    Phytomedicine; 2017 Jan; 24():1-13. PubMed ID: 28160848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kava: Piper methysticum.
    Pepping J
    Am J Health Syst Pharm; 1999 May; 56(10):957-8, 960. PubMed ID: 10365719
    [No Abstract]   [Full Text] [Related]  

  • 18. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of traditional kava (Piper methysticum) use on cognition: Implications for driver fitness.
    Aporosa S'; Ballard H; Pandey R; McCarthy MJ
    J Ethnopharmacol; 2022 Jun; 291():115080. PubMed ID: 35151837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kava for Generalized Anxiety Disorder: A Review of Current Evidence.
    Ooi SL; Henderson P; Pak SC
    J Altern Complement Med; 2018 Aug; 24(8):770-780. PubMed ID: 29641222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.